A personalized view on cancer immunotherapy
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference168 articles.
1. Combining immunotherapy and targeted therapies in cancer treatment;Vanneman;Nature Reviews Cancer,2012
2. New promising drug targets in cancer- and metastasis-initiating cells;Mimeault;Drug Discovery Today,2010
3. Overview of monoclonal antibodies in cancer therapy: present and promise;Stern;Critical Reviews in Oncology/Hematology,2005
4. Current approaches and future directions in the treatment of HER2-positive breast cancer;Hurvitz;Cancer Treatment Reviews,2013
5. An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors;Burgess;Molecular Cell,2003
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cell-membrane engineering strategies for clinic-guided design of nanomedicine;Biomaterials Science;2024
2. The apoptotic effects of NK-92 cells stimulated with an anti-CD226 antibody on MDA-MB-231 triple-negative breast cancer cells;Medical Oncology;2023-07-06
3. The Apoptotic Effects of NK-92 Cells Stimulated with an anti-CD226 Antibody on MDA-MB-231 Triple-Negative Breast Cancer Cells;2023-05-25
4. The effects of KIR2DL4 stimulated NK-92 cells on the apoptotic pathways of HER2 + /HER-breast cancer cells;Medical Oncology;2023-04-07
5. The Effect of an Educational-Supportive Intervention on the Perceived Stress and Nutritional Status of Breast Cancer Patients Undergoing Chemotherapy;Medical-Surgical Nursing Journal;2023-03-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3